$43 Million NIH Grant Expands Global Early-onset Alzheimer’s Study
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

The National Institute on Aging has awarded Washington University School of Medicine a five-year, $43 million grant to expand the Dominantly Inherited Alzheimer Network Observational Study. The project plans to double its more than 750 participants and will study inherited Alzheimer’s, including people who remain healthy past the expected age of onset and those receiving amyloid-targeting treatment.

Washington University School of Medicine in St. Louis will receive a five-year, $43 million award from the National Institute on Aging, part of the National Institutes of Health, to expand its global study of inherited early-onset Alzheimer’s disease. The Dominantly Inherited Alzheimer Network Observational Study has enrolled more than 750 people since 2008; the new funding is expected to double the number of participants.

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

The observational study, known as DIAN Obs, follows people with rare gene mutations that cause Alzheimer’s at a relatively young age, along with relatives who did not inherit those mutations. Researchers use memory assessments, brain scans and analyses of blood and spinal fluid to track changes associated with the disease. The report says about three-quarters of participants had no symptoms when they joined, giving researchers a way to study disease processes before noticeable memory problems.

The network is based at WashU Medicine and includes U.S. institutions and sites in 10 other countries. The grant will build on a recent expansion into Latin America, led by Jorge J. Llibre-Guerra, an associate professor of neurology and associate director of the network. Researchers also plan to focus more on people who inherited a disease-causing mutation but stayed healthy beyond the age when symptoms would have been expected.

The study is observational, but its findings support the Knight Family DIAN Trials Unit, which runs prevention research. Participants in the observational study can provide a comparison group for people receiving experimental treatments. The team is also tracking some people treated with amyloid immunotherapy, including individuals who have received it for more than 10 years, according to the report.

At a glance
announcementWhen: Announced November 2026; funding covers…
The developmentA new five-year, $43 million National Institute on Aging grant will expand WashU Medicine’s international observational study of dominantly inherited Alzheimer’s disease.

Tracking Alzheimer’s Before Symptoms

Inherited Alzheimer’s mutations give researchers an unusually informative timeline: families can often estimate when symptoms may begin, allowing scientists to study biological changes years or decades beforehand. That can help researchers examine which changes precede dementia and when a treatment might have the best chance of affecting the disease course.

The work could also inform research on the more common, late-onset form of Alzheimer’s. DIAN director Eric McDade told News-Medical that the biology of inherited and late-onset disease appears similar. That is a rationale for studying these families, not proof that findings or treatments will transfer directly to all people at risk.

The expanded cohort may also help researchers investigate resilience: why some people carrying a mutation remain well beyond their expected age of onset. Understanding those cases could point to factors that protect against symptoms, although the grant announcement does not establish what those factors are or whether they can be used in treatment.

Products Worth Considering

Therabody Theragun Prime Plus Heated Deep Tissue Massage Gun, Black

Therabody Theragun Prime Plus Heated Deep Tissue Massage Gun, Black

As an affiliate, we earn on qualifying purchases.

From Family Study to Prevention Trials

John C. Morris, a WashU Medicine neurologist, launched the observational network in 2008. The project follows people who inherited a mutation and relatives who did not, helping researchers compare disease-related changes across groups. In dominantly inherited Alzheimer’s, a child of a parent carrying a relevant mutation has a 50% chance of inheriting it; the source report says nearly everyone who inherits one develops dementia, often in their 40s or 50s.

The observational project is distinct from the DIAN Trials Unit. That unit launched its first prevention trial in 2012 and is testing interventions in people at risk before symptoms. McDade is leading an international primary-prevention trial that includes participants up to 25 years before symptoms are expected. The trial is testing whether an amyloid-targeting drug can prevent plaques from forming; this is a research question, not an established preventive effect.

“That design lets us enroll far fewer people and show regulators how a drug alters the disease’s course.”

— Eric McDade, as quoted by News-Medical

Questions the Expansion Cannot Yet Answer

The announcement does not specify the exact enrollment target, how many additional international sites will be added, or how the $43 million will be allocated across study activities. It also does not give a detailed schedule for recruitment or report new findings from the ongoing research.

Researchers hope the study will clarify resilience, long-term amyloid clearance and the effects of immunotherapy, but those questions remain under investigation. The source material does not establish that amyloid-targeting treatment prevents Alzheimer’s, nor that results from people with inherited mutations will apply equally to the wider population.

Enrollment and Long-Term Follow-Up

Over the five-year award period, the team plans to expand enrollment, build on its Latin American work and continue repeated assessments of participants across the international network. Those follow-ups are intended to capture disease changes over time, including in people with inherited mutations who remain symptom-free past their expected onset age.

Researchers will also continue tracking people receiving amyloid immunotherapy and use observational data to support prevention trials. The grant announcement sets out those research priorities but provides no dates for specific milestones or results. Any conclusions about treatment effects will depend on evidence from the ongoing follow-up and clinical trials.

Key Questions

Who received the $43 million grant?

Washington University School of Medicine in St. Louis received a five-year award from the National Institute on Aging, part of the NIH, to expand the DIAN observational study.

What is the DIAN observational study?

It is an international study of people with inherited mutations that cause early-onset Alzheimer’s and relatives who did not inherit those mutations. Researchers track memory, brain imaging and biological measures over time.

Will the grant fund an Alzheimer’s treatment?

The award supports the observational study, which helps researchers understand disease development and supports prevention research. It is not described as a treatment grant, and the source does not report that an experimental drug has been shown to prevent Alzheimer’s.

How much will the study grow?

The project has enrolled more than 750 people and plans to double its participant count. The report does not provide a specific final enrollment number or recruitment timeline.

Source: news-medical.net

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Cyclosporiasis Foods To Avoid

Health officials warn against consuming certain produce as cyclosporiasis outbreak spreads across US states, linked to contaminated food sources.

How Hurricanes Affect Hospitalizations And Deaths Among Older Adults Using Electricity-dependent Medical Devices

A North Carolina study links greater hurricane flooding with hospitalizations and deaths among older Medicare beneficiaries using powered medical devices.

5 Social Security Myths That Cost Retirees Real Money

Diving into these five Social Security myths could save you thousands—discover the truth before it’s too late.

Doctors Share the One Balance Exercise You Should Do After 60

I discovered the essential balance exercise doctors recommend after 60 to prevent falls, and here’s how you can master it for better stability.